1220696-38-7 Usage
General Description
1-Methyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one is a chemical compound with the molecular formula C17H20BNO2. It is a boronic acid derivative commonly used in organic synthesis as a building block for pharmaceuticals and agrochemicals. 1-Methyl-5-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one possesses a unique boron-containing heterocyclic structure, making it useful in Suzuki-Miyaura cross-coupling reactions and other carbon-carbon bond forming reactions. It is also an important intermediate in the production of various drugs and materials like dyes and pigments. Additionally, it has potential applications in the field of materials science and organic electronics due to its π-extended conjugated system and electron-accepting properties.
Check Digit Verification of cas no
The CAS Registry Mumber 1220696-38-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,0,6,9 and 6 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1220696-38:
(9*1)+(8*2)+(7*2)+(6*0)+(5*6)+(4*9)+(3*6)+(2*3)+(1*8)=137
137 % 10 = 7
So 1220696-38-7 is a valid CAS Registry Number.
1220696-38-7Relevant articles and documents
PYRAZOLYL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS
-
Page/Page column 185; 187, (2021/06/26)
The present application provides a compound of formula (I) or a stereoisomer thereof, or an atropisomer thereof, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable salt of a stereoisomer thereof, or a pharmaceutically acceptable salt of an atropisomer thereof; method for manufacturing said compound, and its therapeutic uses. The present application further provides a combination of pharmacologically active agents and a pharmaceutical composition comprising said compound.
IMIDAZOPYRAZINES AS LSD1 INHIBITORS
-
Paragraph 0589, (2016/02/26)
The present invention is directed to imidazo[1,2-a]pyrazine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.
HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS
-
Paragraph 0318; 0319, (2016/10/27)
The present invention is directed to compounds of Formula I which are LSD1 inhibitors useful in the treatment of diseases such as cancer.
